20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Avantor Inc (AVTR) operates in the MEDICAL INSTRUMENTS & SUPPLIES industry and is headquartered in Radnor, United States with about 13,500 employees. Its market capitalization is roughly $10 billion. In the fiscal year ended 2025-12-31, AVTR reported $6.6B in revenue and ($530M) in net income.
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
Interactive charts & full statements → Open the AVTR valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $6.6B | $6.6B | $6.8B | $7.0B | $4.9B | $7.4B | $6.4B | $6.0B | $5.9B | $1.2B | $691M | $637M |
| Gross Profit | $2.1B | $2.1B | $2.3B | $2.4B | $2.6B | $2.5B | $2.1B | $1.9B | $1.8B | $433M | $320M | $262M |
| Gross Margin % | 31.8% | 32.6% | 33.6% | 33.9% | 53.0% | 33.9% | 32.5% | 31.8% | 31.0% | 34.7% | 46.2% | 41.2% |
| Operating Income (EBIT) | ($286M) | ($246M) | $1.1B | $696M | $1.1B | $972M | $707M | $552M | $414M | ($210M) | $10M | $60M |
| Operating Margin % | -4.3% | -3.8% | 16.0% | 10.0% | 23.0% | 13.2% | 11.1% | 9.1% | 7.0% | -16.9% | 1.4% | 9.5% |
| Net Income | ($578M) | ($530M) | $712M | $321M | $686M | $573M | $117M | $38M | ($87M) | ($113M) | ($42M) | $22M |
| Net Margin % | -8.8% | -8.1% | 10.5% | 4.6% | 14.0% | 7.8% | 1.8% | 0.6% | -1.5% | -9.0% | -6.1% | 3.4% |
| EBITDA | $20M | $139M | $1.5B | $1.1B | $1.5B | $1.4B | $765M | $880M | $815M | ($160M) | $70M | $121M |
| Earnings Per Share (EPS) | $-0.85 | $-0.78 | $1.04 | $0.47 | $1.01 | $0.95 | $0.20 | $0.09 | $-0.18 | $-0.23 | $-0.09 | $0.04 |
| Shares Outstanding (M) | 677M | 679M | 682M | 678M | 679M | 600M | 583M | 401M | 496M | 496M | 491M | 534M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $1.7B | $1.6B | $1.7B | $1.6B | $1.7B | $1.6B | $1.7B | $1.7B |
| Gross Profit | $537M | $501M | $524M | $526M | $554M | $535M | $563M | $564M |
| Gross Margin % | 31.7% | 31.7% | 31.5% | 32.4% | 32.9% | 33.8% | 33.4% | 32.9% |
| Operating Income (EBIT) | $122M | $115M | $126M | ($649M) | $129M | $147M | $638M | $125M |
| Operating Margin % | 7.2% | 7.3% | 7.6% | -40.0% | 7.6% | 9.3% | 37.8% | 7.3% |
| Net Income | $38M | $43M | $52M | ($712M) | $65M | $64M | $500M | $58M |
| Net Margin % | 2.2% | 2.7% | 3.1% | -43.8% | 3.8% | 4.1% | 29.7% | 3.4% |
| EBITDA | $121M | $216M | $224M | ($541M) | $228M | $228M | $730M | $226M |
| Earnings Per Share (EPS) | $0.06 | $0.06 | $0.08 | $-1.04 | $0.09 | $0.09 | $0.73 | $0.08 |
| Shares Outstanding (M) | 677M | 679M | 679M | 682M | 682M | 682M | 683M | 683M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $597M | $624M | $841M | $870M | $844M | $954M | $930M | $354M | $200M | ($168M) | $73M | $125M |
| Capital Expenditures (CapEx) | $142M | $129M | $149M | $146M | $133M | $111M | $62M | $52M | $38M | $25M | $30M | $21M |
| Free Cash Flow (FCF) | $455M | $495M | $692M | $724M | $710M | $842M | $868M | $302M | $163M | ($193M) | $43M | $104M |
| FCF Margin % | 6.9% | 7.5% | 10.2% | 10.4% | 14.5% | 11.4% | 13.6% | 5.0% | 2.8% | -15.4% | 6.2% | 16.3% |
| Dividends Paid | — | — | $0M | $18M | $32M | $65M | $65M | $31M | $31M | $1.7B | $159M | $2M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $178M | $59M | $153M | $207M | $154M | $109M | $173M | $245M |
| Capital Expenditures (CapEx) | $38M | $34M | $36M | $36M | $30M | $28M | $28M | $41M |
| Free Cash Flow (FCF) | $141M | $25M | $117M | $172M | $125M | $81M | $146M | $204M |
| FCF Margin % | 8.3% | 1.6% | 7.0% | 10.6% | 7.4% | 5.1% | 8.6% | 11.9% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.6B | $11.8B | $12.1B | $13.0B | $13.5B | $13.9B | $9.9B | $9.8B | $9.9B | $10.4B | $1.1B |
| Cash & Cash Equivalents | $307M | $365M | $262M | $263M | $373M | $302M | $287M | $187M | $185M | $185M | $63M |
| Total Liabilities | $6.0B | $6.2B | $6.2B | $7.7B | $8.6B | $9.7B | $7.2B | $7.3B | $13.0B | $13.1B | $1.6B |
| Total Debt (Short + Long-Term) | $3.7B | $3.9B | $4.1B | $5.5B | $6.3B | $7.0B | $4.9B | $5.1B | $6.9B | $7.1B | $1.3B |
| Total Shareholders' Equity | $5.6B | $5.6B | $6.0B | $5.3B | $4.9B | $4.2B | $2.7B | $2.5B | ($3.1B) | ($2.6B) | ($375M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AVTR viewer.
About TickerBase · Data methodology & sources · Privacy · Terms